Loren Israelsen on What the Industry Can't Afford to Miss Right Now

A quick note before you listen: we recorded this conversation before UNPA announced it will close at the end of 2026, following Loren Israelsen’s retirement after 34 years leading the organization and 46 years in the industry. It’s a solid record of the perspective he’s brought to this space for decades.

In this episode, Len Monheit sits down with Loren Israelsen, Founder and President of the United Natural Products Alliance (UNPA), for a wide-ranging conversation on the forces reshaping the dietary supplement industry. Together, they discuss everything from geopolitics to regulatory momentum to the creeping influence of AI.

Loren and Len unpack what six-plus years of compounding disruption through COVID, geopolitical realignment, tariff volatility, and supply chain fragility actually means for companies trying to plan and compete in 2025 and beyond. They dig into the US-China-India dynamic, including what the ashwagandha situation in India reveals about the deeper tension between traditional Ayurvedic practice and modern nutraceutical development, and why “made in USA” is harder to deliver than consumers realize.

On the regulatory front, Loren offers a frank assessment of what the current FDA leadership alignment means for the supplement industry, and why this moment may be unlike any other in recent memory. From unusually supplement-friendly remarks, to the real prospects for HSA expansion, to the long-standing definition challenges under DSHEA, this conversation is a candid read on where things stand and what the industry needs to do in the next six months.

They close with a conversation that’s harder to summarize but impossible to skip: what happens to an industry built on discovery, trust, and human connection when AI starts doing the thinking, and the writing, for everyone?